Toll Brothers Inc (TOL) and Housing Market Dynamics

Page 1 of 2

Whether we are looking at the residential spending part of the latest GDP report, new home sales, existing home sales, or the decline in foreclosure inventory, we see signs of a slightly improving real estate market.  The recent Toll Brothers Inc (NYSE:TOL) earnings announcement suggests continuation of this trend.  But there are developments that raise flags and give investors reason to continue to approach this arena with trepidation.  While more-aggressive investors might find opportunities in recent stock-price weakness, more risk-averse investors might want to sit on the sidelines for a bit longer.  Here are some things to consider.

Toll Brothers Inc (NYSE:TOL)Examining earnings

Toll Brothers announced its first-quarter earnings on February 20.  In the three months ended January 31, the company posted a per-share profit of $0.03, marking a significant improvement from the loss of $0.02 per share in the year-earlier period.  The EPS gain came amid a 32% increase in revenue (both in terms of volumes and dollars).  The results are solid, even if the company reportedly missed analyst estimates.  Further, conditions look relatively rosy going forward.  Douglas C. Yearley, Jr., Toll Brothers Inc (NYSE:TOL)’s CEO, is quoted in the earnings announcement stating: “Demand has increased. With our first quarter contracts up 49%, and contracts for the first three weeks of our second quarter up 40% versus comparable periods in FY 2012, it appears that momentum is building.”

That’s the good news.  The part that concerns me about the overall housing market came in the next paragraph: “We are continuing to gain market share and see little competition from local private builders.”  That’s good for Toll Brothers Inc (NYSE:TOL), but this brings several questions to mind, and we will have to see how other developers’ earnings come in before we can answer them.  After all, Toll Brothers operates in 19 states, covering the southwest, south central, north central, and much of the east coast.  To get a better picture of other markets, we will need to wait to hear from other companies.  For example, builders KB Home (NYSE:KBH) and Hovnanian Enterprises, Inc. (NYSE:HOV) report earnings in March.  KB Home is one of the oldest home-building companies.  It is well-positioned in ten states, primarily in the south, and the southern parts of both the east and west coast.  Toll Brothers also operates in nine of these states.  By comparison, Hovnanian is positioned in 16 states, all but four overlap with Toll Brothers.

As a general thought, I would like to know how much of Toll Brothers’ recent business comes from market share gains and how much comes from actual strengthening in the housing market.  Admittedly, Toll Brothers operates in the more affluent spectrum of the market, so its earnings report really doesn’t tell us too much about the rest of real estate.  I can’t help but be a bit concerned about the part that they aren’t seeing too much competition from private builders.  For that reason, it is a good idea to take a look at the economic statistics that cover more of the real estate market.

What the statistics tell us

The latest housing statistics continue to show that the real estate market is improving, but it isn’t great.  Still, there are signs to be somewhat hopeful down the road.

According to the government, new single-family home sales in December 2012 were up 8.8% from the year-earlier period, but were down 7.3% from November.  (The government releases January’s statistics on February 26.)  Similarly, new housing starts in January were up considerably from the prior-year level (23.6%), but were down on a month-to-month basis (8.5%).

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

Most Famous Gay Athletes

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!